Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06860516Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
This study (NCT06860516) is an observational trial of adults aged 18-55 with type 1 diabetes diagnosed within 6 months. It aims to collect demographic and HLA data.
San Francisco, CaliforniaAges 18–55 - NCT06931275Recruiting
Reducing technology gaps in type 1 diabetes care
This trial tests if sending reminders to doctors can help more Black and Hispanic people with type 1 diabetes get access to helpful diabetes technology. It aims to reduce unfair differences in who gets to use these tools.
Boston, MassachusettsAges 2–95 - NCT06943001Recruiting
Telehealth program to prevent diabetes in Hispanic teens
This trial tests a telehealth program to help Hispanic teens who are obese prevent type 2 diabetes. It takes place from home and uses your own cellphone.
Houston, TexasAges 14–16 - NCT07006272Recruiting
Closed-loop pump vs islet transplant for unstable type 1 diabetes
This study compares two advanced treatments for type 1 diabetes that is hard to control: a closed-loop insulin pump system (which automatically adjusts insulin) versus islet cell transplantation (which replaces the cells that make insulin). It is for people whose blood sugar stays very unstable despite using the best current therapies.
Lyon, Auvergne-Rhône-AlpesAges 18 years+ - NCT07126873RecruitingPhase 1/Phase 2
Study of E-islet 01 for type 1 diabetes with severe low blood sugar
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07142252RecruitingPhase 2
New drug for recently diagnosed type 1 diabetes
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
Aurora, ColoradoAges 8–45 - NCT07241221Recruiting
Myo-inositol supplement for diabetes in pregnancy
This study tests whether taking a supplement called myo-inositol (a natural vitamin-like substance) during pregnancy can help manage blood sugar in women with type 2 diabetes. It may improve outcomes for you and your baby.
Singapore, SingaporeAges 21–45 - NCT07468474Recruiting
Finding Type 1 Diabetes Risk and Offering Education
This study is designed to help identify and monitor people at high risk for type 1 diabetes. It involves education and regular check-ups to better understand and manage the condition.
Beijing, Beijing MunicipalityAges 4 years+ - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT07573228Recruiting
Obesity's effect on insulin action and fitness in Type 1 Diabetes
This study examines how excess weight affects how insulin works in small blood vessels and overall fitness in people with Type 1 Diabetes. Researchers want to understand if obesity makes diabetes management harder and whether this knowledge can help future treatments.
Charlottesville, VirginiaAges 21–50 - NCT07456774Enrolling by invitation
How long do people stay on Ozempic for diabetes (China study)
This study looks at how well people in China stick with taking Ozempic (a once-weekly injection) compared to other diabetes medicines. It helps researchers understand if this medicine is easier to keep taking long-term.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05662462Recruiting
Phone coaching to keep blood sugar in range during pregnancy
This study tests whether technology plus coaching can help pregnant people with type 2 diabetes keep their blood sugar in a healthy target range. You may use a smartphone app and, if assigned to that group, a device that tracks glucose continuously.
Columbus, OhioAges 18 years+ - NCT06217302RecruitingPhase 3
Sotagliflozin for kidney protection in type 1 diabetes
This study tests whether sotagliflozin (a pill that helps control blood sugar and protects the kidneys) can slow down kidney function decline in people with type 1 diabetes and diabetic kidney disease. You may qualify if you have had type 1 diabetes for at least 8 years, have moderate kidney damage, and are on standard treatments.
Stanford, CaliforniaAges 18–75 - NCT06902597Recruiting
Sarcopenia and nerve damage in type 1 diabetes: a pilot study
This study looks at whether muscle loss (sarcopenia) is related to diabetic nerve damage in adults with type 1 diabetes. If you join, you will help researchers understand this connection better.
Rome, LazioAges 50–80 - NCT07173543Recruiting
Type 2 Diabetes and Brain Health Study for Adults 60–85
This study looks at how type 2 diabetes affects blood flow in the brain and thinking ability. It compares people with diabetes to those without, and may help understand how to protect brain health.
Iowa City, IowaAges 60–85 - NCT07678736Recruiting
Muscle health and early heart risk study
This study looks at how your muscles might show early signs of future heart or blood sugar problems. You'll have a muscle check and follow some meal guidelines.
Ghent, East FlandersAges 20–30 - NCT07449039Recruiting
Blood sugar tracking after pregnancy for diabetes risk
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
Los Angeles, CaliforniaAges 18 years+ - NCT05416060Recruiting
Digital diabetes coaching for Spanish- or English-speaking adults
This study tests a phone/text-based program to help adults with type 2 diabetes manage their health better. It’s designed for Hispanic/Latino people who may have higher blood sugar based on a recent HbA1c level.
Chula Vista, CaliforniaAges 18 years+ - NCT06774014Recruiting
Heart failure and diabetes: cell study
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
Leeds, West YorkshireAges 18 years+ - NCT06047262RecruitingPhase 2
Testing dapansutrile for type 2 diabetes and related problems
This trial tests if a drug called dapansutrile can help control blood sugar and reduce inflammation in people with type 2 diabetes. It may also help prevent or manage diabetes-related complications.
LiègeAges 18–75 - NCT02390973Recruiting
Bariatric-style surgery vs best diabetes care for long remission
This trial compares surgery plus follow-up care versus the best non-surgical (medical) treatment to help people keep type 2 diabetes in remission for a long time. It may be an option if you have higher body weight and diabetes that’s not well controlled, but safety checks are strict.
Québec, QuebecAges 18–60 - NCT07482072Recruiting
Brain blood flow and sugar study for Alzheimer's and diabetes
This study uses brain scans to see how blood flow and sugar transport work in people with both Alzheimer's disease and type 2 diabetes. It may help doctors understand how these conditions interact and find better treatments.
HerlevAges 60–90 - NCT07732777Recruiting
AI-assisted insulin pump study for type 1 diabetes
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
Nanjing, JiangsuAges 14–65 - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,080 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.